Growing 20.1% while insiders sell for 20 straight quarters — Lynch would ask why those running the show won't buy a ticket.

This framework sees a fast grower spending 464.8% of operating cash flow on R&D while insiders sell for 20 straight quarters — a story entering its late innings.

What type of company is this, and what should we expect?

This framework classifies Atlassian as a fast grower — Lynch's favorite category where "10-to-40-baggers" hide. But this fast grower burns cash on R&D at extreme rates while generating negative operating income, suggesting growth at any cost rather than disciplined expansion.

Are we in the early, middle, or late innings of this growth story?

This framework sees late innings. Revenue hitting the 98th percentile while compensation costs explode suggests the easy growth is behind us. The story is well-known — 31 analysts cover it, institutions own most of it, and growth rates are decelerating from earlier peaks.

Insiders might sell for any reason, but they buy for only one — are they buying?

Lynch's asymmetric insight rings alarm bells here — insiders haven't bought once in 20 quarters. When those running the company sell relentlessly during supposed hypergrowth, they're voting with their wallets that the stock isn't cheap.

Is the P/E ratio fair relative to the growth rate?

PEG analysis impossible with negative earnings, but the framework notes a stark disconnect — 20.1% FCF growth versus market pricing in just 1.36% perpetual growth. Either the market sees something insiders see (hence their selling), or it's overly pessimistic.

Applying Lynch's framework reveals a fast grower in late innings — revenue at record highs while insiders sell relentlessly and profitability remains elusive. The 20-quarter selling streak from those who know the business best contradicts institutional accumulation. Lynch loved fast growers but demanded they "make sense" — a company burning 464.8% of operating cash on R&D while diluting shareholders at record rates doesn't make sense. When the growth story requires a PhD to explain and insiders won't buy their own stock, would Lynch look elsewhere?

This analysis applies Peter Lynch's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Peter Lynch. Educational purposes only. Not financial advice.